Related Experiment Video
Updated: Jun 16, 2025
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
Published on: January 31, 2025
Reoperation for hematoma in patients on perioperative antithrombotic drugs underwent thyroidectomy
Bassam Abboud1, Christopher Abboud2, Mayssam Meouche1
1Division of General Surgery, Geitaoui Hospital, Faculty of Medicine, Lebanese University, Beirut, Lebanon.
Backgrounds:
Evaluate the risk of reoperation for postoperative hematoma (POH) in patients on antithrombotic conditions underwent thyroidectomy.
Methods:
Three groups: Groups 1, 2, and 3 included thyroidectomy without treatment, under antiplatelet and anticoagulation drugs, respectively. Occurrence of POH identified 2 groups: hematoma (Group A) and no hematoma (Group B).
Results:
The overall incidence of POH was 6 %(reoperation 0.1 %, conservative 5.9 %). 83 % of the reoperation for POH occurred within the first 24 h. Antiplatelet and anticoagulant drugs were associated with a 3.4 and 5.2 increased odds of POH respectively. Hyperthyroidism, substernal goiter, hypertension, and antithrombotic drugs were present in 32 % and 7 %, 33 % and 11 %, 52 % and 27 %, and 30 % and 9 % of patients in groups A and B respectively. Reoperation was necessary in 0.08 %, 0.23 %, and 1 % of patients in groups 1, 2, and 3 respectively.
Conclusions:
Patients underwent thyroidectomy under antithrombotic drugs are at much higher risk for reoperation for POH.
